1 - 2 / 2 1 |
1. Sinergistično delovanje ibrutiniba in idelalisiba z agonisti receptorja EP4 na celicah kronične limfocitne levkemije Damjan Avsec, 2018, magistrsko delo Ključne besede: kronična limfocitna levkemija, ibrutinib, fludarabin, sinergizem, idelalisib, L-902, 688, PgE1-OH, prostaglandinski receptor tipa 4 (Ep4) |
2. The role of proteasome, immunoproteasome and autophagy in the therapy of chronic lymphocytic leukemia Damjan Avsec, 2023, doktorsko delo/naloga Ključne besede: CLL, proteasome, immunoproteasome, autophagy, targeted therapy, resistance, ibrutinib, idelalisib, venetoclax, NFκB, B-cell receptor |